| INSILICO MEDICINE |
| China |
| Gesundheit |
| KYG4790P1037 / A41XT7 |
| O15 (Frankfurt) |
| FRA:O15, ETR:O15, O15:GR |
| - |
| https://insilico.com/ |
|
InSilico Medicine Cayman TopCo is an artificial intelligence-based biotechnology company focused on drug discovery and development. It leverages generative AI through its Pharma.AI platform, an end-to-end software and automation solution that enhance..
>Volltext.. |
| 2570.79 Mio. EUR |
| 2074.68 Mio. EUR |
| 122.15 Mio. EUR |
| -3.8 Mio. EUR |
| -268.3 Mio. EUR |
| -0.48 EUR |
| 17.83 Mio. EUR |
| 324.33 Mio. EUR |
| 42.17 Mio. EUR |
| 8.47 |
| 161.16% |
| -593.45% |
| - |
| - |
| - |
| - |
| INSILICO |
| 15.11.26 |
|